NeuBase Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NeuBase Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2020 to Q3 2023.
  • NeuBase Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $5.06M, a 9.81% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $5.06M -$551K -9.81% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $5.18M -$569K -9.9% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $5.3M -$587K -9.98% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.41M -$432K -7.4% Dec 31, 2022 10-Q 2023-11-09
Q3 2022 $5.61M -$331K -5.56% Sep 30, 2022 10-QT 2023-06-05
Q2 2022 $5.75M -$298K -4.92% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $5.88M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $5.84M Dec 31, 2021 10-Q 2022-02-11
Q3 2021 $5.95M +$5.95M Sep 30, 2021 10-K 2022-12-21
Q2 2021 $6.05M Jun 30, 2021 10-Q 2021-08-13
Q3 2020 $0 Sep 30, 2020 10-K 2021-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.